Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Tuberous Sclerosis Complex-1 (TSC1) contributes to selective neuronal vulnerability in Alzheimer's Disease.

Journal article

Adriaanse BA. et al, (2023), Neuropathol Appl Neurobiol

Anterior optic pathway pathology in CNS demyelinating diseases

Conference paper

Pisa M. et al, (2022), Brain, 145, 4308 - 4319

Quantification of upper limb dysfunction in the activities of the daily living in persons with multiple sclerosis

Journal article

Pisa M. et al, (2022), Multiple Sclerosis and Related Disorders, 63, 103917 - 103917

Identification of early neurodegenerative pathways in progressive multiple sclerosis

Journal article

Kaufmann M. et al, (2022), Nature Neuroscience

Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS).

Journal article

Dobson R. et al, (2022), Mult Scler Relat Disord, 63

Out with the old, in with the new: Could plasma exchange be used to fill a therapeutic gap in neurology?

Journal article

Spencer JI. et al, (2022), Journal of the Neurological Sciences, 432, 120056 - 120056

Objective biomarkers for clinical relapse in multiple sclerosis: a metabolomics approach.

Journal article

Yeo T. et al, (2021), Brain Commun, 3, fcab240 - fcab240

Contemporary Neuroscience Core Curriculum for Medical Schools.

Journal article

Gelb DJ. et al, (2021), Neurology

Natalizumab‐induced acquired perforating dermatosis

Journal article

Fisher RM. et al, (2021), Clinical and Experimental Dermatology

Load More